IDT Australia Limited (IDT.AX)

AUD 0.1

(0.0%)

Market Cap (In AUD)

42.26 Million

Revenue (In AUD)

13.22 Million

Net Income (In AUD)

-5.41 Million

Avg. Volume

294.78 Thousand

Currency
AUD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.077-0.145
PE
-
EPS
-
Beta Value
1.197
ISIN
AU000000IDT0
CUSIP
Q4866E114
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Paul Anthony McDonald
Employee Count
-
Website
https://en.idtaus.com.au
Ipo Date
1988-04-01
Details
IDT Australia Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (APIs) and finished dose form products in Australia and internationally. It offers analytical method development, stability chambers, and chemistry and microbiology quality control laboratory services. The company also provides project management, chemical, analytical chemistry, pharmacy, clinical packaging, and regulatory affairs, as well as pharmaceutical development services in various dosage forms. In addition, it offers medicinal cannabis products, as well as various contract manufacturing services. The company was founded in 1975 and is headquartered in Boronia, Australia.